In Vitro Fertilization (Ivf) Market Reports & Male And Female Fertility Treatment Market by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Size, Trends, Analysis, Opportunities, Segmentation & Forecast 2015-2021

Infertility is one of the biggest areas of concern across the globe. One out of six couples suffers from some form of infertility. About 10% women aged 20-44 suffer from infertility. There are various reasons for infertility, which include physiological, genetically induced disorders and at times may be self-induced as in the case of contraceptive surgeries. Infertility treatment is a multi-billion dollar industry, which was valued at $ billion in 2014. The key factors driving the market include rising awareness among couples about various infertility treatments, aggressive focus on healthcare infrastructure specifically in terms of infertility treatments in developing economies, low cost treatment options and increase in new options for infertility treatment such as surrogacy. Medical tourism has been a key enabler for the growth in the infertility treatment market.

In vitro fertilization (IVF) methods contribute the largest percentage of revenue (73.26) to the overall treatment market. The treatment segment includes pre-cycles cost, which involves testing and diagnostic methods. IVF also includes costs for drug and hormonal therapy used during the process to onset ovulation and aid in successful fertilization. Drug and hormone therapy segment, which includes drugs such as Clomid and Gonadotrophin hormone therapy, has a share of 7.28 percent. Market for surgeries is the second largest market with a total share of 10.23 percent. Surgeries are specifically performed to treat physical ailments such as blockage in fallopian tubes, problems in the uterus and reversing vasectomy and tubectomy.

The infertility market segmented on the basis of male and female infertility and further on the basis of testing and treatment was valued at $XXXX billion in 2014 and is expected to grow at a CAGR of 6.2 percent from 2015 to 2021. The global IVF market is majorly driven by rising infertility rate due to various reasons such as changing lifestyles, genetic disorders, and physiological dysfunctions and so on. Also, increasing fertility treatment tourism has enabled the low cost treatment options. Israel is one of the leading countries for fertility treatment tourism. Easy availability of surrogates in developing countries at a very low price is another major driver. Moreover, increasing success rates of IVF is encouraging the patients to undergo the treatment. Despite of various motivators the market is experiencing slower growth rate due to high cost of treatment. The average cost of an IVF cycle is $8,158. Also the legal obligation in different geographies with respect to surrogacy is a major restraint. However, global rise in demand for infertility treatment during the forecasted period and increasing interest of private equity investors in the sector is helping in the growth of IVF market.

Chap 1. Executive Summary 

Chap 2. Market overview 

 2.1. Market Share for Drug & Hormone Therapy  
 2.2. Key buying criteria  
 2.2.1. Treatment options  
 2.2.2. Quality of medical procedures  
 2.2.3. Price of treatments  
 2.2.4. Shift towards medical tourism  
 2.2.5. Reimbursement  
 2.3. Key Findings  
 2.3.1. highest growth in Male infertility treatment segment  
 2.3.2. Fertility tourism- The biggest and the growing trend  
 2.3.3. Upper middle income group is the key target  
 2.3.4. Regulatory environment key market enabler  
 2.3.5. Surrogacy preferred for failures in IVF treatments  
 2.3.6. Technological advancement enhancing success rates of fertility treatments 

Chap 3. Male and Female Infertility 

 3.1. Causes  
 3.1.1. Causes of male infertility  
 3.1.1.1. Medical reasons  
 3.1.1.2. Environmental factors  
 3.1.1.3. Lifestyle issues  
 3.1.2. Causes of female infertility  
 3.1.2.1. Ovulatory disorders  
 3.1.2.2. Poor functioning or damage to fallopian tube and other issues  
 3.2. Ethical issues in infertility treatment 

Chap 4. Market Determinants 

 4.1. Market Drivers  
 4.1.1. Rise in infertility  
 4.1.2. Fertility Tourism  
 4.1.3. Surrogacy also responsible for fertility tourism  
 4.1.4. Technological advancement in healthcare domain  
 4.1.5. Increase in success rate of treatments  
 4.1.6. Increasing acceptance of donor eggs by consumers  
 4.2. Market Restraints  
 4.2.1. Expensive procedure  
 4.2.2. Legal issues  
 4.3. Market Opportunities
 4.3.1. Global requirement for low cost instruments and drugs in IVF  
 4.3.2. IVF an attractive sector for investment for private equity investors  
 4.3.3. Reproductive tourism  
 4.4. Market Challenges  
 4.4.1. Cost barrier for locals in emerging economies  
 4.4.2. Low acceptance of infertility treatment amongst men  
 4.4.3. Multiple births and birth defects 

Chap 5. Market Segmentation 

 5.1. Male Infertility Market  
 5.1.1. Male Infertility tests  
 5.1.1.1. Semen analysis techniques  
 5.1.1.1.1. CASA provides more accurate results in lesser time  
 5.1.1.2. DNA fragmentation  
 5.1.1.2.1. Importance of sperm DNA fragmentation  
 5.1.1.2.2. When the test is conducted  
 5.1.1.2.3. Causes of Sperm DNA fragmentation  
 5.1.1.3. Oxidative Stress Analysis  
 5.1.1.4. Testicular Biopsy  
 5.1.1.5. Azoospermia is the reason in 15 percent infertile males  
 5.1.1.6. Risks in testicular biopsy  
 5.1.1.7. CNB and FNA Mapping is an emerging trend
 5.1.2. Male infertility treatment types  
 5.1.2.1. Surgery  
 5.1.2.1.1. Vasovasectomy and Vasoepididymostomy (Vasectomy reversal)  
 5.1.2.1.2. Sperm Retrieval Treatment  
 5.1.2.1.2.1. Microsurgical Sperm Aspiration (MESA)  
 5.1.2.1.2.2. Testicular Sperm Extraction (TESE)
 5.1.2.1.3. Varicocele repairs
 5.1.2.1.4. Drug & Hormone Therapy
 5.1.2.1.5. Assisted Reproductive Techniques (ART)
 5.1.2.1.5.1. Intrauterine insemination (IUI)
 5.1.2.1.5.2. In vitro fertilization (IVF)
 5.1.2.1.5.3. Intra cytoplasmic sperm injection (ICSI)
 5.2. Female infertility
 5.2.1. Female infertility test
 5.2.1.1. Ovulation Testing  
 5.2.1.2. Hysterosalpingography  
 5.2.1.3. Laparoscopy  
 5.2.1.4. Ovarian reserve testing  
 5.2.1.5. Genetic Testing  
 5.2.2. Female infertility treatment types  
 5.2.2.1. In vitro fertilization  
 5.2.2.2. Intrauterine insemination (IUI)  
 5.2.2.3. Drug and hormone therapies 

Chap 6. IVF & Infertility market geography wise 

 6.1. North America  
 6.1.1. US  
 6.1.2. Canada  
 6.1.2.1. Regulation for IVF in Canada  
 6.2. Asia  
 6.2.1. China  
 6.2.2. India  
 6.2.2.1. Growing fertility tourism in India
 6.2.2.2. Need for a regulatory framework
 6.2.3. Japan
 6.2.3.1. Fertility Regulations in Japan  
 6.2.4. South Korea  
 6.2.5. Thailand  
 6.3. Europe  
 6.3.1. Italy  
 6.3.2. France  
 6.3.2.1. Regulations in France
 6.3.2.2. Low cost treatment with social security cover in France
 6.3.3. Germany  
 6.3.3.1. Coverage Policy  
 6.3.3.2. Regulations  
 6.3.4. Spain  
 6.3.4.1. Regulations in Spain  
 6.3.5. Russia  
 6.3.5.1. Regulations 

Chap 7. Company Profiling 

 7.1. Andrology Solutions  
 7.2. Auxilium Pharmaceuticals  
 7.3. Auxogyn  
 7.4. Ferring Pharmaceuticals  
 7.5. Genea  
 7.6. Halotech DNA  
 7.7. Irvine Scientific  
 7.8. Merck Serono  
 7.9. Origio  
 7.10. Ovascience  
 7.11. Vitrolife AB  

Table List

TABLE  1 Global Infertility treatment market by gender 2013-2021 ($Million)  
TABLE  2 Global average cost comparison of various treatments
TABLE  3 Global Male Infertility treatment market in $million (2013-2021)  
TABLE  4 Global female Infertility treatment market in $million (2013-2021)  
TABLE  5 Global Male Infertility Testing Market in $million (2013-2021)  
TABLE  6 Global CASA Market, 2013-2021 (in $million)  
TABLE  7 Advantages & Disadvantages of various DNA shearing methods  
TABLE  8 Global DNA fragmentation market by region, 2013-2021 (in $million)  
TABLE  9 Global oxidative stress analysis market by region, 2013-2021 (in $million)  
TABLE  10 Global sperm penetration assay market by region, 2013-2021 (in $million)  
TABLE  11 Global sperm agglutination market by region, 2013-2021 (in $million)  
TABLE  12 Global microscopic examination market by region, 2013-2021 (in $million)  
TABLE  13 Global Female infertility testing market, 2013-2021 (in $million)  
TABLE  14 Ovulation Testing Kits, US prices  
TABLE  15 Global Ovulation Testing market by region,, 2013-2021 (in $million)  
TABLE  16 Global Hysterosalpingography market, 2013-2021 (in $million)  
TABLE  17 Global Laparoscopy market, 2013-2021 (in $million)  
TABLE  18 Global market for Ovarian reserve testing, 2013-2021 (in $million)  
TABLE  19 Hormone test cost in the US  
TABLE  20 Global average cost of various infertility treatments  
TABLE  21 Global IVF treatment market by region, 2013-2021 (in $million)  
TABLE  22 Global IUI treatment market by region, 2013-2021 (in $million)  
TABLE  23 Global Drug and hormone therapies market by region, 2013-2021 (in $million)  
TABLE  24 Global Infertility treatment market by Geography in $million (2013-2021)  
TABLE  25 North America infertility treatment market, 2013-2021 (in $million)  
TABLE  26 Cost of IVF & ICSI treatment across Canada 2014  
TABLE  27 Asia-Pacific infertility treatment market, 2013-2021 (in $million)  
TABLE  28 Europe infertility treatment market, 2013-2021 (in $million)  
TABLE  29 Average Cost of IVF in Spain  
TABLE  30 Cost of IVF in Russia  

Figures List

FIGURE  1 Market share of infertility treatment segments, 2013  
FIGURE  2 Infertility Drug Market share (%) in 2013  
FIGURE  3 Key buying criteria for infertility treatment  
FIGURE  4 Worldwide falling fertility rate (total births per woman)  
FIGURE  5 Causes of infertility based on gender  
FIGURE  6 Major fertility treatment destination ranking  
FIGURE  7 Number of live births using donor oocyte in the US, (2003-2012)  
FIGURE  8 Percentage of cycles with elective single embryo transfer in women below 35 years  
FIGURE  9 Decline in global fertility rate (birth per woman)  
FIGURE  10 Number of IVF cycles performed in the US  
FIGURE  11 US in infertility treatment market, 2013-2021 (in $million)  
FIGURE  12 Canada infertility treatment market, 2013-2021 (in $million)  
FIGURE  13 Growth rate of the number of IVF clinics in Asia  
FIGURE  14 China infertility treatment market, 2013-2021 (in $million)  
FIGURE  15 India infertility treatment market, 2013-2021 ($million)  
FIGURE  16 Japan infertility treatment market, 2013-2021 ($million)  
FIGURE  17 South Korea infertility treatment market, 2013-2021 (in $million)  
FIGURE  18 Breakdown of foreign patients in South Korea  
FIGURE  19 Thailand infertility treatment market, 2013-2021 (in $million)  
FIGURE  20 Fertility rate in Europe (2013)  
FIGURE  21 Italy infertility treatment market, 2013-2021 (in $million)  
FIGURE  22 France infertility treatment market, 2013-2021 (in $million)  
FIGURE  23 Germany infertility treatment market, 2013-2021 (in $million)   
FIGURE  24 Spain infertility treatment market, 2013-2021 (in $million)  
FIGURE  25 Russia infertility treatment market, 2013-2021 (in $million) 

Request for Sample